Wegovy

Product

Heard on podcasts recently

Wegovy is a brand name for semaglutide, an anti-obesity medication developed by Novo Nordisk for chronic weight management. Administered as a weekly subcutaneous injection, it acts as a GLP-1 receptor agonist to regulate appetite and food intake.

Rank this week

—
Not in this week’s list

Share of the conversation

—

Reach this week

—

Tone this week

—

Not enough signal yet (fewer than 3 episodes scored).

Share of the conversation

Mentions of Wegovy per 1,000 mentions of anything, 7-day rolling, all podcasts.

0.0‰0.05‰0.1‰0.15‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Sep 210.02‰1
Sep 220.02‰1
Sep 250.03‰1
Sep 280.03‰1
Oct 10.03‰1
Oct 30.03‰1
Oct 60.03‰1
Oct 80.03‰1
Oct 100.03‰1
Oct 110.03‰1
Oct 120.04‰1
Oct 160.04‰2
Oct 200.06‰5
Oct 210.07‰1
Oct 220.08‰2
Oct 230.11‰5
Oct 270.07‰1
Oct 280.08‰2
Oct 290.08‰1
Nov 10.05‰2
Nov 20.06‰1
Nov 40.04‰1
Nov 50.04‰1
Nov 80.03‰1
Nov 100.03‰1
Nov 150.02‰1
Nov 160.02‰1
Nov 170.03‰2
Nov 180.04‰1
Nov 190.05‰1

Who is saying what about Wegovy

Verified quotes from the last 90 days: who made the most claims, and which way they leaned.

Discussed alongside

Names that come up in the same conversations as Wegovy.

See 5 more with Pro

Embed this

Paste this on your site to show Wegovy's current trend:

<iframe src="https://podlume.ai/embed/e/wegovy" width="360" height="220" style="border:0" loading="lazy" title="Wegovy on PodLume Trends"></iframe>